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Validation of a Novel Molecular Assay for Swine Brucellosis 




With over 500,000 new cases annually, Brucellosis remains one of the world’s most common 
zoonosis.1 It is known as the world’s most common laboratory acquired infection.2 Species 
within the bacterial genus Brucella can all be characterized as facultative intracellular Gram-
negative coccobacilli.1,3,4 Each species has its own host specificity though transmission from the 
original host to other species, including humans, has been documented.1  
 
B. suis is the second most pathogenic Brucellosis species to humans in the world, and the most 
severe form found in the United States. This is due to the absence of B. melitensis, the most 
pathogenic species, in the United States.4 B. suis was first identified in the United States in 1914 
within feral swine populations. Since then, sporadic cases have been seen in domestic swine 
when interaction has occurred between feral and domestic swine populations. Within a sounder 
an infection could then spread and infect 50-80% of the sounder in a few months.4 These feral 
populations act as a reservoir for B. suis in the same way that elk and bison populations do for B. 
abortus.1,5 Feral swine have also been shown to infect cattle with B. suis when their populations 
overlap and interact for a given time. Brucella organisms enter the host via ingestion, inhalation 
or through contact with skin abrasions. The hallmark of infection amongst food animals is 
spontaneous abortion.  Pastures and water sources can become contaminated if an infected sow 
aborts her fetus in the area. This transmission method is then continued within the swine 
population, spreading it throughout the sounder. 5  
 
There is a low infectious dose for humans. One model estimated that it would only take lung 
exposure of 10-100 organisms6. Concentrations of B.suis are highest in reproductive tissues and 
products of parturition. The placenta from an aborted fetus was shown to have 1010 organisms/g.6 
Though it is rarely fatal in humans, it can be severely debilitating, and is often not diagnosed 
right away. This is due to its common symptoms that are often mistaken for other ailments. 
Symptoms include fever, joint pain, sweating, and constitutional symptoms that may affect a 
variety of human systems.1   
 
Currently, there is no single test that is a direct measure, rapid, and safeguarded for the detection 
of swine brucellosis. Proper diagnosis of B. suis in a laboratory setting relies on tests that have a 
high sensitivity and are specific to B. suis. Current serological tests that look for an antibody 
reaction with the O-antigen polysaccharide (O/PS) in the bacteria’s lipopolysaccharides (LPS) 
can often cross react with other bacterial infections such as Yersinia enterocolitica giving a false 
 
 
positive test result.1,2 This testing method is also unable to distinguish between B. suis and B. 
abortus. This is dangerous when testing cattle that may have interactions with infected swine. 
The current “gold standard” to differentiate between the two is bacterial culture, followed by 
biochemical testing or sequencing. This testing must be done after an animal is euthanized and 
the incubation of the culture takes at least 7 days. Within this time there is risk for exposure to 
those in the laboratory as well as within the herd as the origin of the infection remains unknown 
during that time.2,3  
 
In recent years feral swine have begun to expand into more areas of the United States. In 2014 it 
was reported that an increase from 17 to 38 states with feral hog populations was seen over the 
last 30 years.7 This increases the potential for interactions between feral swine, domesticated 
swine, cattle, and humans, and makes the need for high performing diagnostic tests quite 
apparent. Current research does not show an assay for Brucellosis that has high sensitivity, 
specificity, and maintains a low safety risk for laboratory personnel.  
 
Quantitative polymerase chain reaction (qPCR) is a simple yet effective enzymatic assay. It is 
able to detect and amplify a specific DNA sequence from a sample that may have a diverse pool 
of DNA. The amplified DNA is tagged with a fluorophore so that by measuring fluorescence 
levels one can quantify the amount of target DNA in a sample.8 This can be run from organ 
samples or other sources of DNA including blood or urine. To develop an assay the main 
component is creating primers that will target a DNA sequence unique to your pathogen.7 This is 
important for pathogens that have various species or strains as causative agents to allow for a 
high level of accuracy in the diagnosis process. PCR has been shown as an excellent diagnostic 
assay. Multiple studies have shown PCR to have higher sensitivity and specificity than culture 
methods for diagnosis of bacteria and viruses.9,10,11 
 
The objective of this study is to develop a diagnostic test for distinguishing B. abortus and B.suis 
infections that has high sensitivity, specificity, and is low risk for laboratory personnel. Our 
hypothesis is that a qPCR is an assay that will accomplish the desired goals.  
 
Materials and Methods 
 
Bioinformatics/Bench Validation 
Utilizing Genious software we analyzed the Brucella suis genome to design primer and probe 
sets for a qPCR assay. 13 candidate sets were identified to be used. We selected our preferred set 
to be used and began to optimize our qPCR protocol for that set. We optimized our assay to find 
the prober primer concentration, probe concentration, annealing temperature, and amount of 
added magnesium chloride (MgCl2) that yielded the best results. G blocks (synthetic amplicon 
sequences) were ordered and a dilution curve was performed in order to find the limit of 
detection and quantification of the assay. A specificity experiment was conducted to asses if any 
serological cross-reactors would amplify on our preferred primer/probe set. This included 
additional Brucella spp.   
 
Sample Collection 
Samples were collected from feral hogs from southeastern Texas. Methods of capture included 
trapping, stand hunting, and receiving of already euthanized animals from locals.  Tissues, 
 
 
aqueous solutions (including blood and or urine), and swabs were collected for each animal. 
While working proper decontamination of utensils was performed in between tissues and animals 
to reduce the risk of cross contamination. The tissue samples were immediately frozen at -80°C 
post-collection. Tissues remained frozen for up to one month. They were then shipped to the 
I.D.E.A Lab over dry ice. Samples were stored at -20°C until they were thawed for processing. 
Control animals were taken from Albany County, WY from a production facility that was 
undergoing depopulation for other disease issues. Samples were taken and processed from head 
tissues in an identical manner to those from the feral hogs. 
 
Tissue Processing  
All tissues once thawed were trimmed of excess fat. Working utensils were decontaminated in 
between tissues and animals to minimize cross-contamination risk. Post trimming, half of the 
tissues were cross-hatched and placed in either 50mL or 15mL high-speed conical tubes. The 
other half was placed in whirl-packs and sent to TVMDL for culture.  The conical tubes contain 
garnet zirconia/silica beads and 1x PBS solution (5-20mL depending on conical size) to aid in 
tissue shearing. Conical tubes containing tissues were homogenized post-trimming using an 
Omni Bead Ruptor. The homogenized tissues were frozen at -20°C for 12-24 hours before 
extraction.  
 
DNA Extraction and Concentration 
All tissues, blood samples, and swabs collected from each animal were extracted using kits that 
were predetermined to work well for eluting Brucella spp. Swabs and tissues were extracted 
using an OMEGA kit and blood was extracted on an IBI kit. 400 µL of sample supernatant 
solution was obtained for extraction. Each set included a control to assess if environmental 
factors and/or kit reagents were introducing contamination into sample tubes. These controls 
would be concentrated and run on our qPCR before continuing with concentration of the 
extracted samples. Concentration of the eluted DNA was performed using a ZYMO DNA kit 
which had previously been shown to increase concentration and purity of Brucella spp. Using 
250uL of eluted DNA from the extraction step a 10x concentration was performed leaving 25uL 
of DNA. Another control was used for these sessions to assess reagent or environmental 
contamination that may have been introduced to sample tubes. 
 
qPCR 
Reagents utilized for our qPCr included: nuclease free water, forward annealing primer, reverse 
annealing primmer, probe, MgCl2, and universal probe supermix. These reagents were prepared 
in a dedicated hood to eliminate environmental contamination. The sample template (1 µL) was 
added to the qPCR plate in another separate hood to eliminate environmental and cross-
contamination. All qPCr assays were run in a separate room from that where extraction, 
concentration and qPCR preparation took place to further eliminate contamination possibilities. 
A positive control containing B. suis DNA from the National Veterinary Services Laboratory 
(NVSL) was included in every run.  A non-template control of nuclease free water and controls 
from the concentration sessions were run with each qPCR to assess environmental or reagent-
based contamination.  
 
***All methods were approved by the Institutional Animal Care and Use Committee (IACUC) 










Optimized Preferred Set 
The 104bp-82var- variant of the pan-B. abortus 82bP set was chosen as our preferred 
primer/probe set. Various ranges for primer concentration, probe concentration, MgCl2 
concentration and annealing temperature were tested. The resulting protocol calls for 30 µM 




Our preferred primer/ probe set was ran with additional Brucella spp.  including: B. meltensis, B. 
abortus field strain, vaccine strain 19, and vaccine strain RB51 as wells as known cross-reacting 
species including; O. anthropi, S. enterica serovar Urbana, V. cholerae, Y. enterocolitica O:9, 
and E. coli O157:H7. The experiment showed that only B. suis was amplified (Figure 1).  
 
Limit of Detection 
gBlocks® Gene Fragments (Integrated DNA Technologies) were designed based off the primer 
sequences of the preferred primer/probe set and were thus used as synthetic Brucella suis DNA 
to make a dilution series of 100 -108 target copies per microliter to generate a standard curve for 
this preferred primer/probe set (Figure 2). Each dilution was run in triplicate using one microliter 
of template (gBlocks® Gene Fragments) per well, combined with the previously mentioned 
qPCR reagents in the same concentrations and ran under the same conditions. Non-template 
DNA and a positive control (known Brucella suis DNA-biovar 1, strain 1330) were incorporated 
into the assay to determine if the qPCR reagents were contaminated and/or if environmental 
contamination was present, as well as to ensure the gBlocks® Gene Fragments were being 
recognized and amplified and that the assay was functioning appropriately. The purpose of 
generating standard curve was to calculate limit of detection (LoD- number of bacterium able to 
de detected as defined by, the lowest concentration that can be detected with a 95% confidence 
interval), limit of quantification (LoQ-number of bacterium able to be detected as defined by, the 
lowest concentration that can be accurately quantified), and efficiency (increase in number of 
target DNA sequences per cycle, with 100% being absolutely efficient) to assess the performance 
of this optimized assay protocol. It was found that this novel assay using this optimized 
primer/probe set was able to detect target DNA as low as 102 target copies per microliter where 




213 feral hogs (Sus scrofa) were collected from Southeast Texas. This region was chosen as it 
had previously reported prevalence of 12% for B. suis.12 34 control hogs were collected from 
Southeast Wyoming, a non-endemic region. In total 3374 samples were collected. This included 
 
 
634 swabs and urine, 510 blood samples, and 2230 tissue samples. The number of samples 
collected per animal varied based on sex and pregnancy status. (Figure 3) 
 
Both blood samples of serum and EDTA tubes were stored on ice post-collection for 24-48 
hours. The serum tubes were sent to Texas Veterinary Medical Diagnostic Laboratory (TVMDL) 
for serologic testing using the Rose Bengal Test. The EDTA tubes were centrifuged and the 
blood fractions of plasma, buffy coat, and red blood cells were separated off to be extracted.  
 
Of the 34 control hogs 32 were female and 2 were male. 30 of the female hogs were adult (over 1 
year of age) and the remaining 2 were juvenile. Both male control hogs were juvenile. There 
were 109 female feral hogs of the 213 collected. 57 were adult and 52 were juvenile.  
 
None of our control hogs tested as positive for Brucellosis on any of the diagnostic tests 
(serology, culture, or qPCR) 
 
 
Measures of Agreement, Sensitivity and Specificity 
 
To compare the agreement of the three diagnostic tests, Cohen’s Kappa was calculated on an 
animal to animal level. Comparison were made of qPCR vs Culture, qPCR vs Serology and 
Culture vs Serology. Culture and qPCR agreement were also calculated on a tissue to tissue 
matching basis. qPCR had a moderate agreement (K=0.41-0.60) to both serology and culture. 
Serology was highest at K=0.58, then animal to animal culture K=0.49 and finally tissue to tissue 
culture K=0.43. When the current validated tests of serology and culture, they had good 
agreement (K=0.61-0.80) of K=0.63 (Figure 4).  
 
Sensitivity and specificity were also calculated with a 95% confidence interval (Figure 5). In 
comparing the current diagnostic tests of serology and culture a lower specificity,73.3%, is seen. 
This lowering means that serology had more positives than culture and as culture is the gold 
standard these were deemed, “false positives.” Comparing qPCR to serology showed a lowered 
sensitivity of 62.2% in contrast to the 93.8% specificity. This indicates more animals were called 
positive by serological testing then by qPCR. Finally, in comparing culture to qPCR both on the 
animal and tissue level contrasting results were seen. The animal to animal comparison had a 
high sensitivity, 94.12%, but a lowered specificity,60.7%. On tissue to tissue matching there was 
a low sensitivity of 43.1% while specificity was much higher at 96%. These two comparisons 
indicate that PCR called more animals positive than culture and that even on animals that both 





B.suis in a Household Pet  
 
In collaboration with TVMDL we found what we know to be the first reported case of B. suis in 
a household pet. A canine presented with similar clinical signs to B. canis including swelling of 











Figure 1: qPCR from specificity experiment showing amplification of only B. suis  
 
Figure 2: Standard curve for the preferred primer/probe set (104 base pairs in length). The 
standard curve was generated using gBlocks® Gene Fragments (synthetic Brucella suis DNA) to 










Figure 4:Cohen’s Kappa calculations showing levels of agreements amongst diagnostic assays 
 
 
Male Female (Not Pregnant)  Pregnant Female 
Mandibular LN Mandibular LN Mandibular LN 
Gastro Hepatic LN Gastro Hepatic LN Gastro Hepatic LN 
Medial Retropharyngeal LN Medial Retropharyngeal LN Medial Retropharyngeal LN 
Internal Iliac Internal Iliac Internal Iliac 
Tonsil Tonsil Tonsil 
Superficial Inguinal Superficial Inguinal Superficial Inguinal 
Nasal Swab Nasal Swab Nasal Swab 
Oral Swab Oral Swab Oral Swab 
Prostate Vaginal Swab Vaginal Swab 
Testes Uterus Uterus 
Epididymis Ovaries Ovaries 
Bulbourethral Kidney Kidney 
Seminal Vesicles  Urine Placenta 
Kidney Serum Blood Tube Amniotic Fluid 
Urine EDTA Blood Tube Fetal Lung 
Serum Blood Tube  Urine 
EDTA Blood Tube  Serum Blood Tube 
  EDTA Blood Tube  
Test 1 Test 2  Agreement 
Serology qPCR K= 0.58 Moderate Agreement 
Culture  Serology K=.63 Good Agreement 
Culture (Animal to Animal) qPCR  K=.49 Moderate Agreement 
Culture (Tissue to Tissue) qPCR K=.43 Moderate Agreement 




Serology qPCR Se= 62.2%  
Sp=93.8% 
False negatives in 
qPCR 
Culture  Serology Se=91.7% 
Sp=73.3% 
False positives in 
serology 
Culture (Animal to 
Animal) 
qPCR  Se= 94.12% 
Sp=60.7% 
False Positives in 
qPCR 








Figure 5: Sensitivity and Specificity calculations (95% confidence interval) of diagnostic assays. 





Our measures of sensitivity and specificity are very telling of each of our diagnostic tests. 
Serology tends to detect more positives than both culture and qPCR. However, as previously 
mentioned serological cross reactors are the likely cause for such false positives. Our test has 
high sensitivity when compared with culture on an animal to animal basis. This indicates that our 
test is able to accurately detect all disease positive animals that culture is. In addition, our test 
has found more positives than culture. This is what brings down our specificity, but it does not 
definitively indicate an ineffectiveness of our assay. This may be due to low bacterial burdens 
within the tissues of infected animals. Infected animals may only have 1-100 bacterium 
present.11 This makes it difficult for any diagnostic test to detect infection. However, culture is 
also hindered in that Brucella is a difficult bacterium to grow and is a slow growing organism. 
This means no growth may be seen even after a prolonged time. It is thought that only 30-50% of 
seropositive animals are culturable.2 These two variables mean that a sample may contain 
Brucella, but the organism is too few and grows to slow to out compete other microorganisms 
that are present. Based on what we know about Brucella, it would suggest that the discrepancies 
between culture and qPCR are true positives missed by culture. When looking at culture and 
qPCR on a tissue to tissue basis, our values were inversed from the animal to animal matching. 
This indicates that even on animals that both tests called positive, the two tests are not detecting 
the organism on the same samples. In previous studies we have seen that the bacteria localize 
within tissue which could explain some discordance between qPCR results and culture. Our 
protocol required that culture and qPCR were testing different sections of the same organs. IF the 
bacterium were localized to only one side of the tissue, this would explain why only one test was 
able to detect it.  
 
The main strength of our research is that we have developed a novel molecular assay that 
accurately detects B. suis DNA. We successfully collected many samples that harbored B. suis 
DNA. This was done with no evidence of cross contamination during field collection, trimming, 
extracting, concentrating, or qPCR plating. When compared with the current gold standard of 
culture our assay had near perfect sensitivity. Additionally, our assay had an increased detection 
ability than culture. Finally, we were also able to show for what we believe to be the first time of 
B. suis transmission to a Texas ranch dog. This has implications in minimizing all risks of B. suis 
infections spilling over into human populations.   
 
Our research was limited due to localization and low bacterial burden of Brucella bacteria. Our 
current limit of detection (LoD) is 137 copies of bacteria. As mentioned, infected animals may 
have a bacterial burden that is lower than this. This warrants development of a protocol for 
whole tissue homogenization in order to increase our DNA capture potential and overall assay 
sensitivity. Further optimization of our primer/probe set is also warranted to attempt to lower our 
LoD. Another limitation is that, as of now we have 17 culture positive and 28 culture negative 
hogs. The ideal amount for validation would be 30 of each. Not all hogs have been processed on 
culture so our total amount could change, but for now this limits our ability to validate our 
diagnostic test. However, based on our current results our qPCR has near perfect sensitivity, 




Future directions for this project include the continuation of sending animals to TVMDL for 
culture. From there we may move to the development of a multiplex qPCR for the detection of B. 
suis and B. abortus at the same time for faster turnaround on serologic reactor livestock. 
Amplicon sequencing may be done to determine if there is B. suis DNA in our PCR positive but 
culture negative samples. This will help to strengthen the results of our qPCR despite 
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